(Q37810630)

23 August 2017

1 reference

title

HIV-1 infection in haemophilia (English)

1 reference

23 August 2017

0 references

R Madhok

1

1 reference

23 August 2017

C D Forbes

series ordinal

2

1 reference

23 August 2017

publication date

1 January 1990

1 reference

Best Practice and Research: Clinical Haematology

23 August 2017

published in

1 reference

23 August 2017

volume

3

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

79-101

1 reference

Prevalence of antibody to HTLV-III in haemophiliacs in the United Kingdom

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Long-term evaluation of HIV antigen and antibodies to p24 and gp41 in patients with hemophilia. Potential clinical importance

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Epidemiological parameters of HIV transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Unusually high incidence of tuberculosis among boys with haemophilia during an outbreak of the disease in hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

A new high-potency glycine-precipitated antihemophilic factor (AHF) concentrate. Treatment of classical hemophilia and hemophilia with inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Transient antibody to lymphadenopathy-associated virus/human T-lymphotropic virus type III and T-lymphocyte abnormalities in the wife of a man who developed the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Effect of blood transfusions on colonic malignancy recurrent rate

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Acute encephalopathy coincident with seroconversion for anti-HTLV-III.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Abnormalities of circulating lymphocyte subsets in haemophiliacs in an AIDS-free population

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Antibody to human immunodeficiency virus (HIV) and suboptimal response to hepatitis B vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Transmission of non-A, non-B hepatitis by heat-treated factor VIII concentrate

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Coincidental appearance of LAV/HTLV-III antibodies in hemophiliacs and the onset of the AIDS epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Loss of human immunodeficiency virus type 1 (HIV-1) antibodies with evidence of viral infection in asymptomatic homosexual men. A report from the Multicenter AIDS Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Non-A non-B hepatitis after transfusion of factor VIII in infrequently treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Blood transfusion and tumour growth: evidence from laboratory animals

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Immunological abnormalities in haemophilia: are they caused by American factor VIII concentrate?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Infection of chimpanzees by human T-lymphotropic retroviruses in brain and other tissues from AIDS patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Incidence of symptoms and AIDS in 146 Swedish haemophiliacs and blood transfusion recipients infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Three-year incidence of AIDS in five cohorts of HTLV-III-infected risk group members

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Burkitt lymphoma in a patient with classic hemophilia receiving factor VIII concentrates

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Progressive liver disease in haemophilia: an understated problem?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Inactivation of viruses in labile blood derivatives. II. Physical methods

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Virus safety of solvent/detergent-treated antihaemophilic factor concentrate

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Blood transfusions and survival after lung cancer resection

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Changes in the life expectancy of patients with severe haemophilia A in Finland in 1930-79.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Clinical Investigation of Intermediate- and High-Purity Antihaemophilic Factor (Factor VIII) Concentrates

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Acquired immunodeficiency syndrome among patients attending hemophilia treatment centers and mortality experience of hemophiliacs in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Reduced risk of non-A, non-B hepatitis after a first exposure to 'wet heated' factor VIII concentrate

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). The New York University Medical Center experience with 105 patients (1981-1986)

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Life expectancy of Swedish haemophiliacs, 1831-1980.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Mysteries of HIV: challenges for therapy and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Inactivation by wet and dry heat of AIDS-associated retroviruses during factor VIII purification from plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Histometric studies on cellular infiltrates of tuberculin tests in patients with haemophilia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Human T-lymphotropic virus type III (HTLV-III) infection in seronegative haemophiliacs after transfusion of factor VIII.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Thermal inactivation of the acquired immunodeficiency syndrome virus, human T lymphotropic virus-III/lymphadenopathy-associated virus, with special reference to antihemophilic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Antibody response to human immunodeficiency virus in homosexual men. Relation of antibody specificity, titer, and isotype to clinical status, severity of immunodeficiency, and disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Seroconversion for HTLV-III since 1980 in British haemophiliacs

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

HTLV-III antibody in sequential plasma samples: from haemophiliacs 1974-84.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Impaired cell mediated immunity in haemophilia in the absence of infection with human immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Extranodal lymphoma in a haemophiliac negative for antibody to HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Asymptomatic liver disease in haemophiliacs

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Non-A, non-B hepatitis after factor VIII concentrate treated by heating and chloroform

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Prospective study of hepatitis after factor VIII concentrate exposed to hot vapour

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Incubation period of AIDS in patients infected via blood transfusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

In vitro thrombogenicity tests of factor IX concentrates

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Case for concluding that heat-treated, licensed anti-haemophilic factor is free from HTLV-III.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Observations on plasma banking and transfusion procedures for haemophilic patients using a quantitative assay for antihaemophilic globulin (AHG).

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Production of High-Potency Concentrates of Antihemophilic Globulin in a Closed-Bag System

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Sterilisation of hepatitis and HTLV-III viruses by exposure to tri(n-butyl)phosphate and sodium cholate.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Coincident classic hemophilia and "idiopathic" thrombocytopenic purpura in patients under treatment with concentrates of antihemophilic factor (factor VIII).

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

The Walter Reed staging classification for HTLV-III/LAV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Preliminary survival analysis of UK AIDS data

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Treatment of haemophilia and related disorders in Britain and Northern Ireland during 1976-80: report on behalf of the directors of haemophilia centres in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with hemophilia and no previous transfusions

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Incomplete inactivation of hepatitis B virus after heat treatment at 60 C for 10 hours

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

The effect of activated prothrombin-complex concentrate (FEIBA) on joint and muscle bleeding in patients with hemophilia A and antibodies to factor VIII. A double-blind clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

HLA haplotype A1 B8 DR3 as a risk factor for HIV-related disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Association of HTLV-III Antibodies and Cellular Immune Status of Hemophiliacs

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

HTLV-III infection associated with glandular-fever-like illness in a haemophiliac

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Diversity of clinical spectrum of HTLV-III infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Structure of human factor VIII

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Inactivation and partition of human T-cell lymphotrophic virus, type III, during ethanol fractionation of plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Expression of active human factor VIII from recombinant DNA clones

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

Hepatitis B vaccination of 113 hemophiliacs: lower antibody response in anti-LAV/HTLV-III-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980082-4

7 January 2021

10.1016/S0950-3536(05)80082-4

Identifiers

DOI

1 reference

23 August 2017

1 reference